The global oxygen therapy market is witnessing strong growth, driven by increasing prevalence of chronic respiratory illnesses, government incentives, and rising awareness about supplemental oxygen therapy. Valued at USD 39.74 Billion in 2025, the market is projected to grow at a CAGR of 6.83% from 2026 to 2035, reaching USD 76.94 Billion by 2035.

Oxygen therapy, including concentrators, portable oxygen systems, and liquid oxygen devices, is essential for patients with chronic obstructive pulmonary disease (COPD), severe asthma, cystic fibrosis, and COVID-19-related respiratory complications. Its adoption is further accelerated by the increasing aging population and advancements in portable and home-based oxygen delivery systems.

Market Analysis

The global oxygen therapy market is expanding due to technological innovation, rising chronic disease burden, and favorable government policies supporting patient access to supplemental oxygen. The development of lightweight, portable, and user-friendly oxygen delivery devices is enhancing patient compliance and improving quality of life.

Key Market Drivers

Rising prevalence of chronic respiratory diseases worldwide

Favorable government initiatives and reimbursement policies

Advancements in portable and home-based oxygen delivery systems

Growing awareness among patients and healthcare providers

Technological innovations in oxygen concentrators and monitoring systems

Increasing geriatric population requiring long-term oxygen therapy

Competitive Landscape

Leading companies operating in the global oxygen therapy market include:

Philips Healthcare, Linde Healthcare, Chart Industries, Inc., Invacare Corporation, Smith Pharmacy, Dragerwerk AG & Co. KGaA, Teleflex Incorporated, and Fisher & Paykel Healthcare Corporation Limited.

These players focus on innovative product development, strategic partnerships, and expansion into emerging markets to strengthen their market presence and cater to growing patient needs.

Request a free report sample with a structured, detailed TOC overview.

Future Outlook

By 2035, the oxygen therapy market is expected to witness sustained growth driven by portable and home-based solutions, integration with telehealth, and increasing adoption in chronic disease management. The market will continue to expand as healthcare providers emphasize patient-centric care and technological innovation enhances treatment efficiency.